Max Robotics — Global Service Robot Directory + US Certification

About

Chad Ellimoottil is a health services researcher and urologic surgeon whose work bridges clinical practice and health policy, with a focus on improving value in surgical care. His research centers on understanding and reducing unwarranted variation in healthcare spending and outcomes, particularly in urologic oncology. Ellimoottil’s most cited paper, "Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending" (2018, 21 citations), provides critical real-world evidence comparing surgical approaches, revealing that minimally invasive techniques do not consistently reduce costs or complications, challenging prevailing assumptions. He further explores spending variation in "Physician and facility drivers of spending variation in locoregional prostate cancer" (2020, 6 citations), a landmark study of nearly 39,000 men that identifies key drivers of wasteful spending, informing payment reform strategies. His work on "Use of Routine Home Health Care and Deviations From an Uncomplicated Recovery Pathway After Radical Prostatectomy" (2017, 5 citations) highlights opportunities to optimize postoperative care. Ellimoottil’s contributions are vital for policymakers and clinicians seeking to align reimbursement with patient-centered, high-value care, making him a leading voice in the movement toward evidence-based healthcare reform.